ANDREW PRATT: Open Payments
NPI 1265860159 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$52,078 in 89 payments from 4 companies in 2025. Trend: 2023 $21 · 2024 $34,459 · 2025 $52,078
Speaker / faculty: $40,691Consulting: $5,063Travel & lodging: $4,107Food & beverage: $2,218
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 84 | $51,984 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Alkermes, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: INGREZZA, REXULTI, ARISTADA, Qelbree.
Industry payments across TX — which companies pay providers there.
